Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Pollack

Showing results (221-230 of 265) with videos related to

Pageof 27
Sort By:
Journal of Radiation Oncology|September 28, 2013
Lack of Association between COX-2 Staining Level and Biochemical Recurrence Following Salvage Radiation Therapy for Recurrent Prostate CancerMichael G Heckman, Katherine S Tzou, Alexander S Parker, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2022
Long-Term Results of a Phase 3 Randomized Prospective Trial of Erectile Tissue-Sparing Intensity-Modulated Radiation Therapy for Men With Clinically Localized Prostate CancerEddie Zhang, Karen J Ruth, Mark K Buyyounouski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2020
Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate CancerVladimir Avkshtol, Karen J Ruth, Eric A Ross, et al.
NMR in Biomedicine|November 22, 2023
Uncovering prostate cancer aggressiveness signal in T2-weighted MRI through a three-reference tissues normalization techniqueAhmad Algohary, Evangelia I Zacharaki, Adrian L Breto, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrenceAnson T Ku, Uma Shankavaram, Shana Y Trostel, et al.
Cancers|November 14, 2023
Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRIRadka Stoyanova, Olmo Zavala-Romero, Deukwoo Kwon, et al.
Oncotarget|July 21, 2016
Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsiesRadka Stoyanova, Alan Pollack, Mandeep Takhar, et al.
Prostate Cancer and Prostatic Diseases|September 27, 2024
Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS scoreHelen Y Hougen, Isildinha M Reis, Sunwoo Han, et al.
Urologic Oncology|April 9, 2026
Evaluating MRI findings and biopsy strategies to maximize detection of grade progression in men on active surveillance for prostate cancerSeyed Hossein Hosseini Sharifi, Jonathan T Ryan, Adam Williams, et al.
The Journal of Urology|December 28, 2020
Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted BiopsySanoj Punnen, Radka Stoyanova, Deukwoo Kwon, et al.
Pageof 27

Showing results (221-230 of 265) with videos related to

Sort By:
Pageof 27
Journal of Radiation Oncology|September 28, 2013
Lack of Association between COX-2 Staining Level and Biochemical Recurrence Following Salvage Radiation Therapy for Recurrent Prostate CancerMichael G Heckman, Katherine S Tzou, Alexander S Parker, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2022
Long-Term Results of a Phase 3 Randomized Prospective Trial of Erectile Tissue-Sparing Intensity-Modulated Radiation Therapy for Men With Clinically Localized Prostate CancerEddie Zhang, Karen J Ruth, Mark K Buyyounouski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2020
Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate CancerVladimir Avkshtol, Karen J Ruth, Eric A Ross, et al.
NMR in Biomedicine|November 22, 2023
Uncovering prostate cancer aggressiveness signal in T2-weighted MRI through a three-reference tissues normalization techniqueAhmad Algohary, Evangelia I Zacharaki, Adrian L Breto, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrenceAnson T Ku, Uma Shankavaram, Shana Y Trostel, et al.
Cancers|November 14, 2023
Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRIRadka Stoyanova, Olmo Zavala-Romero, Deukwoo Kwon, et al.
Oncotarget|July 21, 2016
Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsiesRadka Stoyanova, Alan Pollack, Mandeep Takhar, et al.
Prostate Cancer and Prostatic Diseases|September 27, 2024
Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS scoreHelen Y Hougen, Isildinha M Reis, Sunwoo Han, et al.
Urologic Oncology|April 9, 2026
Evaluating MRI findings and biopsy strategies to maximize detection of grade progression in men on active surveillance for prostate cancerSeyed Hossein Hosseini Sharifi, Jonathan T Ryan, Adam Williams, et al.
The Journal of Urology|December 28, 2020
Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted BiopsySanoj Punnen, Radka Stoyanova, Deukwoo Kwon, et al.
Pageof 27